PPR (Pan-Retinal Photocoagulation) Argon laser treatment is a recognized ophthalmic procedure used to treat certain retinal conditions. A focused laser beam is applied to specific areas of the retina to stabilize abnormal changes and prevent further deterioration.<\/p>\n\n\n\n
In conditions like diabetic retinopathy, damaged or abnormally growing blood vessels can develop, which may leak or bleed, potentially leading to severe vision loss or blindness. The Argon laser \u201cseals\u201d or \u201cdestroys\u201d these pathological vessels, preventing further damage.<\/p>\n\n\n\n
PPR Argon laser treatment is primarily recommended for:<\/p>\n\n\n\n
It is important to note that this treatment is intended to prevent further deterioration \u2014 it usually does not immediately improve vision. The main goal is stabilization, preserving vision, and preventing blindness.<\/p>\n\n\n\n
PPR Argon laser treatment has been the standard of care for proliferative retinal conditions like diabetic retinopathy for decades. Research shows that it significantly reduces the risk of severe vision loss or blindness in patients with high-risk retinal conditions.<\/p>\n\n\n\n
By destroying damaged and abnormal blood vessels, oxygen supply to the retina is improved, and the formation of new, harmful vessels is reduced. This helps protect the most critical part of the retina \u2014 the macula \u2014 while keeping the rest of the retina stable.<\/p>\n\n\n\n
Because conditions like diabetes are often chronic, continued monitoring may be necessary \u2014 sometimes repeat laser treatments or additional treatments are required.<\/p>\n\n\n\n
The treatment is not intended to restore lost sharp vision; it is intended to prevent further deterioration.<\/p>\n\n\n\n
Sometimes temporary loss of visual field, or a reduction in night vision or color vision, may occur.<\/p>\n\n\n\n